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Abstract
Background: Patients with intra-abdominal sepsis and associated bacteremia have a high mortality rate.
However, outcomes studies in this population are limited, in part because of the small numbers of such patients.
The objective of this study was to describe characteristics of critically ill patients with secondary blood stream
infection (BSI) of intra-abdominal origin and identify predictors of mortality.
Methods: This retrospective, single-center study evaluated patients admitted between January 2005 and January
2011 with bacteremia because of an intra-abdominal source. Patients were included if they met criteria for
severe sepsis based on International Classification of Diseases, 9th Revision (ICD 9) codes for acute organ
dysfunction, had a positive blood culture, had at least one ICD 9 code indicative of an intra-abdominal process,
and had a confirmed or clinically suspected intra-abdominal infection (IAI) within 72 h of the blood culture.
Chart review was performed to confirm the presence of these criteria and also the absence of any other potential
source of bacteremia. Data were collected on patient demographics, BSI source, source control procedure
details, microorganisms isolated, and antibiotics administered. Multivariable logistic regression analysis was
performed to identify independent predictors of mortality.
Results: Three hundred six patients with BSI were identified, of which 108 episodes were deemed to be of intra-
abdominal origin. Gram-negative organisms comprised 43% of blood isolates, followed by gram-positives
(33%), anaerobes (14%), and yeast (9%). Appropriate antimicrobial therapy was administered in 71% of patients.
The overall mortality rate was 27.8%. As compared with survivors, non-survivors were older, more likely to have
underlying COPD or asthma, and have renal or metabolic failure (p< 0.05 for all). Among non-survivors,
adequate source control was obtained less frequently (64% vs. 91%, p= 0.002) and median time to appropriate
antibiotics was longer (23 h vs. 4 h, p= 0.004). Logistic regression analysis revealed inadequate source control
(p= 0.002) and inappropriate antibiotics (p= 0.016) to be independently associated with mortality.
Conclusions: Critically ill patients with a BSI of abdominal origin are at high risk for mortality. Failure to
achieve adequate source control and administration of inappropriate antibiotics were independent predictors of
mortality. Thus, these represent potential opportunities to impact outcomes in patients with complicated IAI.
Intra-abdominal infections (IAI) are generally associ-ated with a relatively low frequency of bacteremia. A
retrospective review of 300 patients undergoing percutane-
ous abscess drainage procedures reported bacteremia related
to organisms at the infected intra-abdominal site in only se-
ven patients (2.7%) [1]. Another retrospective review of
1,017 patients with complicated appendicitis managed sur-
gically did not report any cases of bacteremia [2]. The Sur-
gical Infection Society/Infectious Disease Society of
America (SIS/IDSA) guidelines on the management of
complicated IAI (cIAI) conclude that blood cultures are
seldom useful diagnostic adjuncts for IAI [3].
Although obtaining blood cultures in patients with IAI is
not routinely recommended, such patients have a worse
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prognosis than those patients with IAI who do not have a
complicating bacteremia. Bacteremia from a high risk source
such as abdominal and lower respiratory tract has been in-
dependently associated with in-hospital mortality [4]. Fur-
thermore, mortality rates of up to 63% have been reported in
patients who develop a bacteremia of intra-abdominal origin
[5]. Many patients with IAI who have an associated bacter-
emia present with evidence of severe sepsis or septic shock.
However, current IAI guidelines [3] cannot make highly
definitive statements describing optimal therapy for these
severely ill patients because of a lack of prospective studies.
Describing a critically ill group of patients with IAI based on
an objective measurement, such as bacteremia, provides a
different avenue into looking at management, outcome var-
iables, and predictors of mortality.
There have been numerous studies published evaluating
predictors of mortality in patients with IAI [6–11]. However,
studies investigating predictors of mortality in patients with
BSI of intra-abdominal origin are sparse. Two cohort studies
have investigated a total of 1,399 patients with BSI and
deemed 114 to be from an intra-abdominal source [5,12]. The
reported mortality rates in these studies were 36% and 63%.
Acute Physiology and Chronic Health Evaluation (APACHE)
II score, the number of evolving organ dysfunctions, older
age, and occurrence of acute renal failure were independent
risk factors for mortality in these two studies. Interestingly,
receipt of appropriate antibiotics was not identified as a pre-
dictor of outcome, but findings may be limited as a result of
the small sample sizes and definitions applied. In contrast, in
virtually all studies in which it has been examined, inadequate
or delayed source control is a consistent risk factor for an
adverse outcome in patients with cIAI [3,10,11].
Thus, many questions remain unanswered for these se-
verely ill patients with IAI. The objective of this study is to
describe the characteristics of patients with BSI of intra-
abdominal origin who have severe sepsis or septic shock and
determine if independent predictors of mortality can be
identified in those patients.
Patients and Methods
This retrospective, single-center cohort study was per-
formed at Barnes-Jewish Hospital, a 1,250-bed tertiary care
academic medical center which is the major teaching hospital
for the Washington University School of Medicine. This fa-
cility has an emergency department with approximately
100,000 adult patient visits per year. The Washington Uni-
versity School of Medicine Human Research Protection Of-
fice and the Protocol Review and Monitoring Committee
approved this study. The Barnes-Jewish Hospital medical
informatics system was queried to identify patients who were
admitted between January 1, 2005, and January 1, 2011, and
met inclusion criteria. To be included in this study, patients
had to meet criteria for severe sepsis based on discharge
International Classification of Diseases, 9th Revision, (ICD
9), Clinical Modification codes for acute organ dysfunction,
which have been described previously [13]. Organs of in-
terest included the heart, lungs, kidneys, bone marrow (he-
matologic), brain, and liver. Patients also had to have a
positive blood culture and at least one ICD 9 code indicative
of an intra-abdominal process. In patients with multiple ep-
isodes of bacteremia, the first occurrence was utilized for the
timing of bacteremia. Patients were considered to have septic
shock if vasopressors (norepinephrine, dopamine, epineph-
rine, phenylephrine, or vasopressin) were initiated within
24 h of the time of blood culture collection. Patients who
transiently received vasopressor agents related to procedures
or use of anesthesia were not considered to meet this criterion
of septic shock.
Eligible patients meeting these criteria were then orga-
nized in the database according to the highest number of
intra-abdominal related ICD 9 codes and assessed accord-
ingly. In order to increase the probability of identifying a
patient with a suspected IAI, patients with ‡ three intra-
abdominal related ICD 9 codes and were selected for further
review. Each patient chart was then reviewed to confirm
correct ICD 9 codes and the presence of a clinically suspected
IAI within 72 h of the positive blood culture. Once a patient
was deemed to have a BSI of intra-abdominal etiology, a
second reviewer assessed the patient. If there was a dis-
crepancy between the results of the first and second review,
the patient was excluded. Reasons for excluding a patient
included identification of an extra-abdominal source of the
BSI, a failure to identify an obvious source of the BSI, if the
positive blood culture was assessed as being because of a
contaminant, if key documentation was unclear or missing, or
if a decision was made to pursue a non-aggressive approach
to treating the patient within 48 h of the positive BSI.
Electronic medical records were searched to identify de-
mographic data, microbiology data, antimicrobial agents re-
ceived, presence of health care–associated risk factors,
surgical procedures, and the specific source of the IAI.
Baseline characteristics collected included age, gender, race,
history of congestive heart failure, pulmonary disease, diabetes
mellitus, chronic liver disease, malignant disease, and end-
stage renal disease requiring dialysis. A modified APACHE
II score [14] was calculated to estimate the severity of illness
based on clinical data present within 24 h of the positive
blood culture. Additional electronic inpatient and outpatient
medical records available for all patients in the BJC Health-
care System (13 hospitals and multiple community health
locations) were reviewed to determine prior antimicrobial
exposure and surgical history.
All definitions were chosen before initiation of the study.
Community-acquired IAI was defined as infection occurring
less than 48 h after hospital admission, with the absence of
any health care–associated community-onset risk factors.
Health care–associated community-onset was defined as an
IAI in a patient with the presence of at least one of the fol-
lowing health care risk factors: Presence of invasive device at
admission, history of methicillin-resistant Staphylococcus
aureus (MRSA) infection or colonization, history of surgery,
hospitalization, or dialysis in the previous 12mo, or residence
in a long-term care facility, nursing home, or rehabilitation
facility. Heath-care-associated hospital-onset was defined as
an IAI onset greater than 48 h after hospital admission [3].
Adequacy of source control was assessed independently by
two board-certified surgeons ( JEM and EH). A patient was
considered to have had inadequate source control only if both
surgeons concurred with that opinion; if the opinions dif-
fered, the patient was designated as having had adequate
source control. Adequate source control was defined as
having a timely percutaneous, endoscopic, laparoscopic, or
open abdominal procedure to drain infected fluid collections,
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debride infected tissues, and control ongoing enteric or other
drainage producing peritonitis. Procedures were considered
timely if they were performed within 24 h of the discovery of
the intra-abdominal source of infection eliciting the bacter-
emia. Patients who had temporizing procedures performed,
such as damage control laparotomy or temporary abdominal
drainage, were considered to have had adequate source
control if widespread enteric leakage was alleviated and a
plan was established for a more definitive procedure within
the next 24–72 h. In patients with infected pancreatic ne-
crosis, temporizing measures were considered adequate
source control as long as further procedures to control sepsis
were to be undertaken. Patients were considered to have had
inadequate source control if no source control procedure was
undertaken, if the procedure was delayed by more than 24 h,
or if the operative procedure did not result in control of the
ongoing infectious process. For instance, a patient with an
intestinal leak and generalized peritonitis who was treated
with drainage of the peritoneal cavity but with no plan for
subsequent definitive control of the source of the leakage,
would be assessed as having had inadequate source control.
Subsequent recurrence or development of a further intra-
abdominal infection was not utilized as a criterion for judging
adequacy of the index source control procedure; the assess-
ment was based only on the expectation that the procedure
would achieve the objectives listed above. The designation
that a patient had inadequate source control was not an
opinion about surgical judgment or approach, because the
patient’s condition or technical issues may have precluded
performance of a definitive source control procedure.
Appropriate antimicrobial therapy was defined as an
initially prescribed antimicrobial regimen with activity
against the identified pathogen based on in vitro suscepti-
bility testing and administration within 24 h of blood culture
collection. Multi-drug-resistant isolates for gram-negative
bacteria were defined as a bacterial isolate with in vitro
resistance to at least three or more anti-pseudomonal anti-
biotics, which included cefepime, piperacillin-tazobactam,
ciprofloxacin, imipenem or meropenem, or an aminogly-
coside (gentamicin, tobramycin, or amikacin).
Continuous data were analyzed using the Student t-test for
parametric data and the Mann-Whitney U test for non-
parametric data. Categorical data were analyzed using the
Chi-square or Fisher exact test. A p value of less than 0.05
was considered to indicate a statistically significant differ-
ence. A univariate analysis was performed excluding nine
patients who did not undergo a source control procedure.
Logistic regression was used to identify risk factors inde-
pendently associated with mortality. Variables significant at a
p value £ 0.2 in the univariate analyses entered into the
stepwise multivariable logistic regression model. The most
prudent model for the predictors of mortality was computed
and its fit was tested with the AUROC and the Hosmer-
Lemeshow goodness-of-fit test. Statistical analysis was
completed by using the SPSS software, version 18.0 (SPSS,
Inc., Chicago, IL).
Results
A total of 1,310 patients were identified as having a
positive blood culture, ICD 9 codes for severe sepsis and ‡1
ICD 9 code for an intra-abdominal process. A total of 306
patients had ‡ three intra-abdominal related ICD 9 codes
and were selected for further review. The most common
reason for exclusion (n = 104) was the likelihood that an
extra-abdominal source accounted for the bacteremia. Al-
ternative sources of infection included 64 catheter related
BSI, 27 pneumonias, seven urinary tract infections, and six
cardiothoracic infections. In 37 patients, no definitive source of
the BSI was identified. Thirty patients were excluded because
of missing data and 17 were excluded because of suspected
contaminated blood culture. Finally, 10 patients were ex-
cluded because a non-aggressive course of treatment was
selected within 48 h of the positive blood culture. The final
analysis included 108 patients with BSI from an intra-
abdominal source (Fig. 1).
The study patients had a median age of 60 y, with 56%
being male and 44% being female. The majority of patients
were Caucasian (74%). The median modified APACHE II
score for the patients was 20. Seventy-two percent of
FIG. 1. Study profile.
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patients were mechanically ventilated and 94% were ad-
mitted to the ICU during their hospital stay. Most patients
had at least one documented organ failure. IAI was con-
firmed by computed tomography in 83% of patients. Of the
108 patients, 82 (76%) had an intra-abdominal culture ob-
tained during admission. Forty-seven patients had an intra-
abdominal culture obtained within 72 h of their positive
blood culture, with 43 (52.4%) being positive and four being
negative (4.8%). The median overall hospital length of stay
was 27.5 d (Table 1).
Eight percent of patients had an IAI acquired in the com-
munity, 25% had a health care–associated, community onset
IAI, and 67% had health care–associated hospital-onset IAI.
The frequencies of various health care–associated risk factors
are detailed in Table 2. Overall, 43% of patients had received
antimicrobials in the previous 90 d (Table 2). Forty-eight
patients underwent an operative procedure before developing
an IAI, as detailed in Table 3.
The most common presumed source of infection were
gastrointestinal perforations (30%), gastrointestinal necrosis
or ischemia (19%), and intra-abdominal abscess (18%) (Ta-
ble 4). All but nine patients had secondary peritonitis and
underwent a source control procedure. Among these nine
patients, four had SBP, one had cholangitis, one had a sus-
pected anastomotic leak, one had a small bowel obstruction
managed non-operatively, one had infected ascites of un-
known origin, and one had a suspected peritoneal dialysis
(PD) catheter infection. The most common source control
procedures were placement of a percutaneous drain (32%)
and large bowel resection (26%). An adequate source control
procedure was considered to have been performed in 83 of
Table 1. Clinical Characteristics
Characteristic *n = 108
Age, years 60 (50.3–70.0)
Male 60 (55)
Modified APACHE score 20 (14.0–26.0)
Ethnicity
Caucasian 80 (74.1)
African American 21 (19.4)
Other 7 ( 6.5)
Comorbid conditions
Hypertension 47 (43.5)
Coronary artery disease 22 (20.4)




Malignant disease 43 (39.8)
Immunosuppression 25 (23.1)
Cirrhosis 16 (14.8)




Hemodialysis dependent 3 ( 2.8)
Chronic pancreatitis 2 ( 1.9)





Hepatic 9 ( 8.3)
Hematologic 35 (32.4)
Metabolic 39 (36.1)
Neurologic 8 ( 7.4)
Sepsis with acute organ dysfunction 64 (59.3)
Vasopressors 90 (83.3)
ICU admission 101 (93.5)
Hospital length of stay, days{ 27.5 (14.0–43.1)
Positive intra-abdominal culture
within 72 h of positive blood culture
43/82 (52.4)
No abdominal culture obtained 26 (24.1)
CT confirmed IAI 90 (83)
*values reported as n (%) unless otherwise specified.
{value reported as median (inter-quartile range).
APACHE =Acute Physiology and Chronic Health Evaluation;
IAI= Intra-abdominal infection; ICU = Intensive care unit; CT=
computerized tomography.
Table 2. Risk Factors for Infection
with Resistant Pathogens
Characteristic *n = 108
Community acquired 9 ( 8.3)
Health care associated community-onset 27 (25)
Health care associated hospital-onset 72 (66.7)
Hospitalized in the last month 62 (57.4)
Hospitalized in the last 3mo 7 ( 6.5)
Hospitalized in the last 6mo 1 ( 0.9)
Hospitalized in the last 12mo 6 ( 5.6)
Presented from home 58 (53.7)
Presented from nursing home
or extended care facility
7 ( 6.5)
Presented from outside hospital 43 (39.8)
Received antimicrobials in the previous 90 d 46 (42.6)
MRSA colonization 15 (13.9)
VRE colonization 25 (23.1)
Total parental nutrition 53 (49.1)
*values reported as n (%) unless otherwise specified.
{value reported as median inter-quartile range.
MRSA=methicillin-resistant Staphylococcus aureus; VRE =
vancomycin-resistant Enterococcus.
Table 3. Invasive Abdominal Procedures Prior
to Onset of Intra-abdominal Infection
Surgical procedure *n = 108
None 60 (55.5)
Large bowel resection 11 (10.2)
Liver transplant 8 ( 7.4)
Pancreaticoduodenectomy 5 ( 4.6)
Small bowel resection 5 ( 4.6)
Endoscopic procedures 5 ( 4.6)
Cholecystectomy 4 ( 3.7)
Liver resection 4 ( 3.7)
Hernia repair 3 ( 2.8)
Pancreatectomy 3 ( 2.8)
Nephrectomy 2 ( 1.9)
Exploratory laparotomy with adhesiolysis 2 ( 1.9)
Other* 6 ( 5.6)
Patients may have had ‡ one initial surgical or invasive procedure
*Values reported as n (%).
*other: one exploratory laparoscopy, one gastric bypass, one
gastrojejunostomy, one oophorectomy and cystotomy repair, one
percutaneous gastrostomy, one splenectomy.
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the 99 patients who underwent such a procedure (84%)
(Table 5).
Gram-negative organisms were the most commonly iso-
lated organisms, (61/141, 43%) with Escherichia coli being
the most common microorganism cultured (25/141, 18%).
Enterococcus spp. was the most common gram-positive or-
ganism isolated (26/141, 18%). Anaerobes were present in
14% of the BSIs and fungal isolates were found in 9%. A
polymicrobial BSI was noted in 20% of patients (Table 6).
VRE was isolated in 9% of the BSI episodes, MDR gram-
negative bacilli in 4%, and MRSA in 4%.
Appropriate antibiotic therapy was administered to 71% of
the patients. The most common initial antimicrobials pre-
scribed were vancomycin (71%) and piperacillin-tazobactam
(44%), followed by metronidazole (32%), and cefepime
(25%). Of note, 8/13 (62%) of bacteremias because of VRE
Table 4. Source of Infection
Blood stream infection source *n = 108
Gastrointestinal perforation 32 (29.6)
Colon perforation 20 (18.5)
Small bowel perforation 10 ( 9.3)
Other perforation* 2 ( 1.9)
Gastrointestinal necrosis or ischemia 20 (18.5)
Abscess 19 (17.5)
Anastomotic leak 13 (12)
Cholangitis 13 (12)
Pancreatitis 8 ( 7.4)
Spontaneous bacterial peritonitis 4 ( 3.7)
Complicated cholecystitis 2 ( 1.9)
Bile leak 2 ( 1.9)
Other infection{ 7 ( 6.5)
*Values reported as n (%)
Note: Some patients had ‡ one BSI infection source.
*Other perforation: one gallbladder, one gastric.
{Other infection: two infected hepatic infarcts, one PD catheter,
one toxic megacolon, one infected ascites with unidentified source,
one pelvic infection, one bladder perforation.
BSI = blood stream infection; PD= peritoneal dialysis.
Table 5. Source Control Procedure(s) Performed
Source Control Procedure n= 108
None 9 ( 8.3)
Percutaneous drainage 35 (32.4)
Large bowel resection 28 (25.9)
Small bowel resection 18 (16.7)
Exploratory laparotomy with washout 6 ( 5.6)
ERCP 7 ( 6.5)
Pancreatic debridement 4 ( 3.7)
Repeat liver transplant 3 ( 2.8)
*Others 6 ( 5.6)
Adequate Source Control
Yes 83/99 (84.0)
Values reported as n (%)
Patients may have undergone more than one source control
surgical or invasive procedure
*Others: one ulcer closure with omental patch, one diverting loop
ileostomy, one transverse colotomy repair, one liver abscess








Polymicrobial BSI 22/108 (20.4)
Gram-negative 61 (43.3)
Escherichia spp. 26 (18.4)
E. coli 25
E. hermannii 1
Klebsiella spp. 14 ( 9.9)
K. pneumoniae 13
Enterobacter spp. 7 ( 5.0)
E. cloacae 4
E. aerogenes 3
Pseudomonas aeruginosa 5 ( 3.5)
Proteus mirabilis 2 ( 1.4)












Staphylococcus spp. 12 ( 8.5)
S. aureus 5
S. epidermidis 6
Streptocococcus spp. 6 ( 4.3)
S. pneumoniae 2



















Fungi 13 ( 9.2)





Resistant microorganisms 24 (17.0)
VRE 13 ( 9.2)
MDR gram-negative bacilli 6 ( 4.3)
MRSA 5 ( 3.5)
*Values reported as n (%), *p = 0.005
BSI = bloodstream infection; VRE = vancomycin resistant Enter-
ococcus; MDR =multi-drug resistant; MRSA=methicillin-resistant
Staphylococcus aureus.
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and 9/13 (69%) because of Candida sp. received inappro-
priate antibiotics (Table 7).
The overall mortality rate was 27.8%. The non-survivors
were older, more likely to have underlying chronic obstructive
pulmonary disease (COPD) or asthma, and have renal or
metabolic failure. Survivors more frequently had E. coli BSI,
had an adequate initial source control procedure, and had a
shorter time to receipt of appropriate antimicrobial therapy
(median 4 h versus 23h) (Table 8). Stepwise logistic regression
analysis revealed that inadequate source control (p= 0.002)
and inappropriate antibiotics (p= 0.016) were independently
associated with mortality (Hosmer-Lemeshow p= 0.943,
AUROC= 0.776.) (Table 9).
Discussion
The aim of this study was to describe characteristics of
patients with IAI who have concomitant BSI, and identify
predictors of mortality in this critically ill population. To our
knowledge, this is the first study to date that has assessed
the timing and appropriateness of antimicrobial therapy aswell
as the contribution of inadequate source control in a group of
critically ill patients with an IAI and an associated bacteremia.
Our study findings were similar to De Waele et al. [5], in
that approximately 20% of patients had a polymicrobial BSI
secondary to an intra-abdominal source. Fewer patients re-
ceived appropriate antimicrobial therapy in this current in-
vestigation compared with the study of De Waele et al. (70%
versus 91%). This is likely because of the differences in the
appropriate antimicrobial therapy definition, for which we
required administration within 24 h of blood culture collec-
tion, compared with 48 h in the previous study. We did not
require a positive intra-abdominal culture in addition to a
positive blood culture for inclusion, as was done in the study
by De Waele et al., because intra-abdominal cultures were
not obtained at our institution in all cases and are not nec-
essary for the clinical diagnosis of an IAI. However, to ensure
that the BSI was most likely because of an intra-abdominal
source, all clinical information was reviewed by at least two
separate investigators to exclude any cases where the BSI was
potentially related to an alternative source.
The mortality rate was substantially lower in the current
study compared with that observed in the study by DeWaele
et al. (28% versus 63%). This may have been because of
differences in baseline comorbidities and slight differences in
the severity of acute illness. In addition, widespread dis-
semination and implementation of the Surviving Sepsis
Campaign guidelines because the previous study may have
contributed to the lower mortality rate noted in our study. De
Waele et al. found age and renal failure to be associated with
a greater mortality rate. Although these factors were both
statistically significantly different in our univariate analysis,
Table 7. Antimicrobial Data and Appropriateness
Appropriate therapy n (%)
Appropriate therapy received 77/108 (71.3)
Inappropriate therapy received
MDR gram-negative bacilli 3/6 (50)
MRSA 0
VRE 8/13 (62)*
Candida spp. 9/13 (69)*
Antimicrobial agent Initial agent Switched to
Added to initial
regimen >24 h later Received for <24 h
Vancomycin 77 (71.3) 4 ( 3.7) 8 (7.4) 5 ( 4.6)
Piperacillin-tazobactam 47 (43.5) 11 ( 10.2) - 10 ( 9.3)
Metronidazole 35 (32.4) 13 ( 12.0) 10 (9.3) 8 ( 7.4)
Cefepime 27 (25.0) 23 ( 21.3) - 6 ( 5.6)
Fluconazole 17 (15.7) 6 ( 5.6) 10 (9.3) 5 ( 4.6)
Meropenem 15 (13.9) 30 ( 27.8) 1 (0.9) 2 ( 1.9)
Micafungin 13 (12.0) 2 ( 1.9) 6 (5.6) 3 ( 2.8)
Anidulafungin 11 (10.2) 2 ( 1.9) 7 (6.5) 2 ( 1.9)
Ciprofloxacin 11 (10.2) 18 ( 16.7) 1 (0.9) 17 (15.7)
Cefoxitin 4 ( 3.7) - - 11 (10.2)
Aminoglycoside 2 ( 1.9) 1 ( 0.9) 7 (6.5) 13 (12.0)
Imipenem 3 ( 2.8) 11 ( 10.2) 2 (1.9) -
Ceftriaxone 2 ( 1.9) 7 ( 6.5) - 2 ( 1.9)
Daptomycin 2 ( 1.9) 11 ( 10.2) 3 (2.8) -
Ampicillin 1 ( 0.9) 5 ( 4.6) - 1 ( 0.9)
Linezolid 1 ( 0.9) 20 (185) 4 (3.7) 3 ( 2.8)
Ertapenem 1 ( 0.9) 5 ( 4.6) - 1 ( 0.9)
Caspofungin 1 ( 0.9) 3 ( 2.8) 4 (3.7) -
Amphotericin 1 ( 0.9) 1 ( 0.9) - -
Colistin 1 ( 0.9) - 3 (2.8) -
Voriconazole - 1 ( 0.9) 2 (1.9) -
Tigecycline - - 2 (1.9) -
values reported as n (%),*p value< 0.05
MDR =multi-drug resistant; MRSA=methicillin-resistant Staphylococcus aureus; VRE = vancomycin resistant Enterococcus.
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they were not shown to be independent predictors of mor-
tality in the multivariable analysis. In a study by Raymond
et al. [15], the mortality rate for surgical patients with IAI
complicated by BSI was 20%, although measures of severity
of illness in this subgroup (n = 46) were much lower than
those observed in the present study. The objective of this
analysis by Raymond et al. was to assess the importance of
BSI among infected surgical patients, and included both IAI
and pneumonia. The presence of a BSI was not shown to be
an independent predictor of death in surgical patients, but
they noted that patients with BSI had a greater severity of
illness and mortality rate.
Inadequate source control and administration of inappro-
priate antibiotics were independent predictors of mortality in
this analysis. Lack of adequate source control was the
strongest predictor of mortality, which is consistent with
other analyses of complicated IAIs, [3,10–11]. However,
what actually represents ‘‘adequate’’ source control is con-
troversial. In general, we considered the goal of source
control to be drainage of infected fluid collections, debride-
ment of infected tissue, and definitive measures to avoid
further contamination, as outlined by Marshall [16]. How-
ever, it has been increasingly recognized in recent years that
less invasive techniques can constitute adequate source
control. For instance, percutaneous drainage of an infected
fluid collection is well accepted as a means of source control,
as long as the goal of elimination of a substantial amount of
the microbial inoculum and prevention of ongoing contami-
nation can be achieved [3]. Indeed, some less invasive
techniques now being utilized, such as laparoscopic drainage
without resection for Hinchey Class III and IV diverticulitis
[17] might have been considered to be inadequate source
control just a few years ago. There is also an appreciation that
damage control laparotomy is an acceptable measure for
initial management of many critically ill patients with intra-
abdominal sepsis, even though this obligates further proce-
dures for definitive management [18].
For this study, therefore, we attempted to restrict the def-
inition of inadequate source control. We only applied this
determination to those cases in which there was a clear failure
to perform a timely source control procedure (defined as
Table 8. Univariate Analysis: Non-Survivors vs. Survivors
Non-survivors Survivors
Variable 25/99 (25.2%) 74/99 (74.7%) p
Age{ 65 ( 54.5–77.5) 57 (49.0–69.0) 0.027
Presented from home 10 ( 40.0) 44 (59.5) 0.091
Presented from outside hospital 13 ( 52.0) 25 (33.8) 0.105
Modified APACHE score{ 23 ( 17.0–27.0) 19 (14.0–25.0) 0.103
Chronic obstructive pulmonary disease or Asthma 8 ( 32.0) 7 ( 9.4) 0.017
Mechanically ventilated 22 ( 88.0) 51 (68.9) 0.061
Organ failure
Cardiovascular 14 ( 56.0) 36 (48.7) 0.525
Renal failure 17 ( 68.0) 32 (43.2) 0.032
Metabolic 14 ( 56.0) 22 (29.7) 0.018
Hospital length of stay{ 34.3 ( 12.5–57.4) 28.8 (14.7–40.9) 0.540
Vasopressors 24 ( 96.0) 61 (82.4) 0.092
ICU admission 25 (100) 68 (91.9) 0.142
Polymicrobial BSI 5 ( 20.0) 15 (20.2) 0.977
Organism
Bacteroides fragilis 5 ( 20.0) 6 ( 8.1) 0.102
Escherichia sp. 2 ( 8.0) 20 (27.0) 0.048
Candida sp. 3 ( 12.0) 10 (13.5) 0.846
Community acquired 1 ( 4.0) 6 ( 8.1) 0.488
Health care–community onset 4 ( 16.0) 20 (27.0) 0.266
Health care–hospital onset 20 ( 80.0) 48 (64.9) 0.158
Inappropriate antimicrobials 11 ( 44.0) 18 (24.3) 0.062
Time to appropriate antimicrobials, h{ 23 ( 6.6–48.6) 4 ( 1–20) 0.004
Source control achieved 16 ( 64.0) 67 (90.5) 0.002
VRE colonization 7 ( 28.0) 13 (17.6) 0.261
MRSA colonization 6 ( 24.0) 8 (10.8) 0.102
Values reported as n (%) unless otherwise noted.
{Values reported as median inter-quartile range.
BSI = blood stream infection; VRE = vancomycin resistant Enterococcus; MRSA=methicillin-resistant Staphylococcus aureus;
APACHE =Acute Physiology and Chronic Health Evaluation; ICU = intensive care unit.
Table 9. Multivariate Logistic
Regression Analysis
Variable AOR, 95% CI p
Inadequate source control 7.46, 2.08–26.32 0.002
Inappropriate antibiotics 3.86, 1.28–11.64 0.016
APACHE II score
(1 point increments)
0.93, 0.87– 1.01 0.084
Hosmer-Lemeshow p = 0.943, AUROC = 0.776.
AOR= adjusted odds ratio; CI = confidence interval; APACHE =
Acute Physiology and Chronic Health Evaluation.
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within 24 h of discovery of an intra-abdominal process for
which source control was needed), or the use of a temporizing
procedure without any apparent plan to carry out a definitive
procedure (e.g., initial percutaneous drainage of an abscess in
a patient with bowel necrosis with no subsequent bowel re-
section). We also required the independent concurrence of two
board-certified general surgeons that there was inadequate
source control. It is likely that this led to an underestimate of
the degree to which inadequate source control was present in
these critically ill patients. Nonetheless, most patients did un-
dergo procedures that seemed in accordance with contempo-
rary surgical practice, so it is unlikely that the narrowness of
this definition resulted in major skewing of the results.
Inappropriate antibiotics were administered more com-
monly in non-survivors and remained as an independent
predictor of mortality in the multivariable analysis. This
finding is consistent with multiple studies that have demon-
strated an association between inappropriate antibiotic use
and increased risk of therapeutic failure and mortality in the
context of IAI [19–22]. This finding emphasizes the need to
tailor empiric therapy utilizing patient specific factors in or-
der to optimize outcomes for patients with IAI. The time to
appropriate antimicrobial therapy was shorter amongst sur-
vivors in the univariate analysis, this but was not indepen-
dently associated with mortality in the multivariable analysis.
The inability to demonstrate such a finding in this cohort of
patients with secondary BSI related to an IAI may have been
because of the relatively small sample size particularly if the
major effect of inadequate source control overwhelmed the
opportunity of seeing a smaller difference related to timing of
antimicrobial therapy in this relatively small study. Indeed, in
a large study of septic shock patients performed by Kumar
et al., an*8% increased risk of death for every 1 h delay in
the administration of appropriate antibiotics relative to the
onset of hypotension was observed [23]. Approximately 30%
of patients included in this study had an intra-abdominal
source of infection and subgroup analysis of this population
was consistent with the overall findings.
The majority of patients in this study had health care–
associated hospital onset infections (67%) followed by
health care–associated community onset infections (25%).
Gram-negative bacilli (most commonly E. coli and K.
pneumoniae) and gram-positive cocci (most commonly
Enterococcus spp.) caused the majority of the BSIs in our
study, followed by anaerobes and yeast; these are also the
common pathogens reported in most studies of IAIs. Al-
though Pseudomonas is an organism associated with many
hospital-acquired infections, it was only present in 3.5% of
the BSIs in our study; this is consistent with its low incidence
(<15%) in cIAI in general [3]. Regardless, most patients in
our study were initially started on an anti-pseudomonal agent
(piperacillin-tazobactam, cefepime, meropenem). Similarly,
MRSA isolation was rare (4%) and consistent with previous
studies, and yet the majority of patients in this cohort re-
ceived an agent with MRSA activity. Multi-drug resistant
gram-negative organisms were also isolated infrequently
(4.3%), with no differences found between survivors and
non-survivors.
Although Candida spp. and VRE collectively accounted
for only 18% of the microorganisms isolated, they were
responsible for more than half [n = 17/31 (55%)] of the oc-
currences of inappropriate antimicrobial therapy. It is also
noteworthy that 9/13 (69%) Candida isolates were non–-
Candida albicans spp. Intra-abdominal infections because
of Candida and enterococci have previously been associated
with increased morbidity and mortality [8,24,25] although
debate exists as to whether this relation is causal or simply an
association [26]. However, when considering these findings in
conjunction with data demonstrating reduced survival when
inappropriate antibiotics are administered, it would appear that
empiric therapy against these potential pathogens should be
considered in the appropriate patient populations in order to
optimize outcomes. However, empiric therapy is not re-
commended in all patients with cIAI, and should only be uti-
lized in patients with substantial risk factors for these
pathogens, as suggested in the SIS/IDSA guidelines [3].
There are several limitations worth noting. The retro-
spective design of this study is one such limitation. Inter-
pretation of diagnoses, infection sources, and surgical
procedures depends on the accuracy of documentation;
thus, some data of the data collected may have been in-
correct. Reliance on ICD 9 codes to identify patients initially
may have led to the unintentional exclusion of some patients
because of the potential for incorrect coding. The majority of
the included patients were healthcare-associated hospital-
onset, limiting the less well represented populations. The
observational design also limits the opportunity to determine
why certain antimicrobial regimens were prescribed initially.
Because this study was conducted at a single center institu-
tion, the results may not be applicable to other institutions.
Finally, as with any observational study, it is not possible to
infer a causal relation between mortality and the patient,
microbial, and management data obtained in this study.
Overall, however, we believe that this study provides
important information about critically ill patients with IAI
and an associated bacteremia. Despite improvements in
therapy, mortality was still high in these patients, with
nearly three of 10 critically ill patients succumbing to an
intra-abdominal infection associated with BSI. Although we
identified several differences between survivors and non-
survivors, including differences in age, underlying organ
failure, and time to appropriate antibiotic delivery, the
major finding was that inadequate source control and in-
appropriate antibiotics were major independent risk factors
associated with increased mortality in these patients. We
would conclude that despite the critically ill nature of these
patients, performance of a timely source control procedure
and administration of appropriate antibiotics is still of pri-
mary importance in managing patients with IAI, and po-
tentially of even greater importance in these severely-ill
patients. Source control should not be delayed in the false
hope that prolonged medical management alone will
somehow improve the patient’s physiological condition
such that overall risk of mortality because of this disease
will be lessened.
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